Filing Details
- Accession Number:
- 0001562180-15-000528
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-25 12:29:03
- Reporting Period:
- 2015-06-24
- Filing Date:
- 2015-06-25
- Accepted Time:
- 2015-06-25 12:29:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1597553 | Sage Therapeutics Inc. | SAGE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1612859 | Stephen Kanes | C/O Sage Therapeutics, Inc. 215 First Street Cambridge MA 02142 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-06-24 | 6,000 | $0.45 | 52,948 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-06-24 | 6,000 | $74.06 | 46,948 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2015-06-24 | 6,000 | $0.00 | 6,000 | $0.45 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
40,300 | 2023-07-23 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- This transaction was executed in multiple trades at prices ranging from $74.00 USD to $74.58 USD. The price reported above reflects the weighted average sale price.
- 25% of this option vested on July 18, 2014, and the remainder vests in equal monthly installments thereafter over 36 months.